Ginekologia Polska · 2018 · 36 citations · 29 references
MedicineCancer BiologyOncologyBreast OncologyMolecular OncologyOncogenesBreast Cancer OncologyCancer BiomarkersEndocrine Tumor PrognosisNoncoding Rna In CancerBreast Cancer Molecular SubtypesBreast Cancer PrognosisEstrogen Receptor StatusHer2 ExpressionHormone Receptor - Positive Breast CancerMicrorna In CancerMicrorna Prognostic MarkersReceptors
INTRODUCTION: Breast cancer can be classified into five subtypes based on variations in the status of three hormonal receptors that are responsible for the cancer's heterogeneity: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These classifications influence the choice of therapies (either neoadjuvant or adjuvant), and the range of prognoses, from good (luminal A subtype) to poor (triple-negative cancers). OBJECTIVE: The aim of the study was to compare the serum concentration of selected miRNAs (miRNA-21, miRNA-10b, and miRNA-200c) between in two groups of breast cancer patients with differing ER, PR, and HER2 statuses. MATERIALS AND METHODS: The study was performed on two groups of patients. One group (TNBC) consisted of patients with triple-negative cancer, and the other group (ER(+)/PR(+)) was comprised of patients with positive ER and PR receptors. RESULTS: The mean level of miRNA-200c was significantly higher in the ER(+)/PR(+) group than in the TNBC group (p < 0.05). No statistically significant difference was found between the two groups with regard to the mean levels of miRNA-21 or miRNA-10b. CONCLUSION: The level of miRNA-200c was lower in triple-negative patients when compared with the levels in the study's ER/PR positive group.
29
Molecular portraits of human breast tumours
Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu et al. · Cancer Research · 2005 · 4.1K citations
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Li Ma, Julie Teruya‐Feldstein, Robert A. Weinberg · Nature · 2007 · 2.6K citations
Medicine, Cancer Biology, Oncology +12
Drug delivery with carbon nanotubes for in vivo cancer treatment
Zhuang Liu, Kai Chen, Corrine R. Davis et al. · PubMed · 2008 · 2.3K citations · Full text
Pharmacy, Oncology, Pharmacology +17